Paediatric neuroblastoma could be treated by nanocells
06 March, 2018EnGeneIC's bacterially derived nanocells are enhancing the delivery of chemotherapy to tumours, while limiting toxicity to normal tissues, in aggressive paediatric neuroblastoma.
Trapping the protein servants of drug-resistant bacteria
05 March, 2018Belgian researchers have devised a novel approach to developing antibacterial drugs, in a breakthrough that is set to combat the rise of antibacterial resistance.
US conjunctivitis treatment funded by the MRCF
28 February, 2018Okogen, a developer of ophthalmic anti-infective drugs, has received $13m from the Medical Research Commercialisation Fund to advance its viral conjunctivitis treatment.
'Thought control' enables spinal injury patient to ride a bike
27 February, 2018 by Lauren DavisGold Coast researchers are using a 3D computer-simulated biomechanical model and an electroencephalogram (EEG) to stimulate movement in quadriplegics.
Next-gen antibody shows promise as lung fibrosis treatment
20 February, 2018A locally developed molecule called an 'i-body' serves as a powerful inhibitor of fibroblast migration in human lungs, providing promising evidence for a new treatment of lung fibrosis.
Obesity-focused start-up attracts $7m MRCF investment
19 February, 2018The MRCF has announced a $7 mllion investment in Cincera Therapeutics, a biotech company seeking to develop therapies targeting conditions relating to an unhealthy diet.
Strong growth reported for Australia's medtech sector
13 February, 2018Australian jobs supported by the medtech, biotech and pharma sector increased by 10% from 2015 to 2016, while manufacturing exports increased by 30%.
Immutep's lead product well tolerated in melanoma trial
12 February, 2018Immutep's lead product has been found safe and well tolerated when combined with pembrolizumab (KEYTRUDA) at doses up to 30 mg per subcutaneous injection.
Electric fields + peptides = better implantable device integration
09 February, 2018Researchers have made a discovery that could help implantable devices better integrate with the body, thus reducing risk of infection.
Protein-based nanoshuttle to deliver anticancer vaccines
07 February, 2018US biomedical engineers are using a natural protein called albumin as a way to 'shuttle' cancer-fighting nanovaccines into the body.
Collaboration to improve outcomes for cochlear implant recipients
29 January, 2018Sensorion and Cochlear have announced a strategic collaboration focused on improving hearing outcomes in patients with cochlear implants.
New drug could halt MS in its tracks
25 January, 2018Monash University researchers are about to conduct a study into a drug that may thwart the progression of multiple sclerosis, following a $70,000 grant from MS Research Australia.
Reform recommended for genetic modification regulations
22 January, 2018Australia's gene technology regulator has proposed reducing regulations around gene editing techniques such as CRISPR, following a 12-month technical review.
One giant LEAP for regenerative medicine
12 January, 2018Exopharm has finalised testing for its disruptive LEAP technology, taking a further step in bringing extracellular vesicles as an acellular therapy to treat patients with degenerative conditions.
Cancer-fighting seaweed
11 December, 2017Animal studies undertaken at UTHealth have shown that the two seaweed extracts — known as fucoidans — have reduced tumour growth in select cancers and significantly improved the effectiveness of the common chemotherapy drug tamoxifen.
